Sakaal, 22 January 2021:

BSV has developed biological, biotechnology products as well as medicines to date. BSV today aims at better outcomes in patients in the field of women's health as well as in the therapeutic field in the context of cataract care and IUI-IVF

Read more:

About BSV

BSV has been a pioneer in the development of blood components and therapeutic antibody products for infectious and non-infectious diseases. For over four decades, BSVL has focused on utilizing its scientific resources to develop several biological, biotechnology and pharmaceutical products to treat various types of diseases, contributing to preserve, protect and enhance the quality of life. We aim to be a leading biopharmaceutical company driven by people & science to set benchmarks in patient outcomes in Women’s Health, Critical Care & Emergency Medicine.

For more information, please contact:

Irawati Gowariker, BSV, Irawati.gowariker@bsvgroup.com